IMPORTANT NOTICE: Our email addresses will soon change. Learn more >>
Loading...

FITC anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_FITC_1_110210
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_1_110210
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_2_110210
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
101205 50 µg 38€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101206 500 µg 106€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Gupta P, Rajan M, Kulkarni S, et al. 2017. Int Immunopharmacol. 10.1016/j.intimp.2017.06.025. PubMed
  2. Haimon Z et al. 2018. Nature immunology. 19(6):636-644 . PubMed
  3. Bijland S, et al. 2019. F1000Res. 8:117. PubMed
  4. Furuhashi K, et al. 2017. Immunology. 151:227. PubMed
  5. Miyatake Y, et al. 2018. J Immunol. 201:3051. PubMed
  6. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  7. Rybova J, et al. 2022. J Inherit Metab Dis. 45:1175. PubMed
  8. Chen Y, et al. 2022. Am J Cancer Res. 12:5286. PubMed
  9. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  10. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  11. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  12. Adzika GK, et al. 2023. Front Immunol. 14:1124649. PubMed
  13. Wang YC, et al. 2023. J Exp Med. 220:. PubMed
  14. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  15. Yang Y, et al. 2023. Cancers (Basel). 15:. PubMed
  16. Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed
  17. Matsuzawa M, et al. 2023. Nat Commun. 14:1417. PubMed
  18. Latour YL, et al. 2023. Gut Microbes. 15:2192623. PubMed
  19. Dona MSI, et al. 2023. Basic Res Cardiol. 118:11. PubMed
  20. Sun JY, et al. 2023. Sci Adv. 9:eade4110. PubMed
  21. Iguchi A, et al. 2023. iScience. 26:106375. PubMed
  22. Han S, et al. 2023. Int J Mol Sci. 24:. PubMed
  23. Zhu CL, et al. 2023. Int J Biol Sci. 19:1413. PubMed
  24. Thai LM, et al. 2023. iScience. 26:106477. PubMed
  25. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  26. Banka AL, et al. 2023. Nat Commun. 14:2462. PubMed
  27. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  28. Qin C, et al. 2023. iScience. 26:106588. PubMed
  29. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  30. Xu Y, et al. 2023. J Cancer. 14:1182. PubMed
  31. Feng X, et al. 2023. Nat Commun. 14:3208. PubMed
  32. Zhang Y, et al. 2023. NPJ Regen Med. 8:28. PubMed
  33. Chen SW, et al. 2023. Methods Mol Biol. 2683:53. PubMed
  34. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  35. Mawambo G, et al. 2023. J Neuroinflammation. 20:145. PubMed
  36. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  37. Kiepura A, et al. 2021. Int J Mol Sci. 22:. PubMed
  38. Guo H, et al. 2020. Curr Protoc Immunol. 131:e107. PubMed
  39. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  40. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  41. Schädlich IS, et al. 2022. iScience. 25:104470. PubMed
  42. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  43. Nesseler JP, et al. 2020. Cancers (Basel). 12: . PubMed
  44. Song R, et al. 2022. Immunology. 165:274. PubMed
  45. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  46. He D, et al. 2022. Immunity. 55:159. PubMed
  47. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  48. Du Y, et al. 2022. FASEB J. 36:e22248. PubMed
  49. van Dierendonck XAMH, et al. 2022. Proc Natl Acad Sci U S A. 119:e2114739119. PubMed
  50. Martin-Martin I, et al. 2022. Cell Rep. 39:110648. PubMed
  51. Liu X, et al. 2022. Adv Sci (Weinh). 9:e2105650. PubMed
  52. Usui-Ouchi A, et al. 2022. Glia. 70:1762. PubMed
  53. Ocaña-Guzman R, et al. 2022. Cells. 11: . PubMed
  54. Li J, et al. 2022. FASEB J. 36:e22400. PubMed
  55. Dong H, et al. 2022. Proc Natl Acad Sci U S A. 119:e2123247119. PubMed
  56. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  57. Komori R, et al. 2022. Int J Mol Sci. 23: . PubMed
  58. Ostendorf BN, et al. 2022. Nature. 611:346. PubMed
  59. Shen Z, et al. 2022. EBioMedicine. 85:104285. PubMed
  60. Xuan FL, et al. 2022. Front Immunol. 13:1005067. PubMed
  61. Foo CX, et al. 2023. Eur Respir J. 61: . PubMed
  62. Zhang Z, et al. 2022. Integr Cancer Ther. 21:15347354221138534. PubMed
  63. Shang T, et al. 2022. Front Pharmacol. 13:1054176. PubMed
  64. Roy S, et al. 2022. Am J Cancer Res. 12:4977. PubMed
  65. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  66. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  67. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  68. Miró L, et al. 2022. Cancers (Basel). 14: . PubMed
  69. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  70. Chen L, et al. 2022. Cancer Immunol Immunother. :. PubMed
  71. Chan L, et al. 2022. Cells. 12: . PubMed
  72. Wang L, et al. 2022. Nutrients. 15: . PubMed
  73. Montilla A, et al. 2023. Cell Death Dis. 14:16. PubMed
  74. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  75. Li Y, et al. 2023. Cell Death Dis. 14:28. PubMed
  76. Freitag K, et al. 2023. Commun Biol. 6:40. PubMed
  77. Schmidt AD, et al. 2023. J Invest Dermatol. :. PubMed
  78. Jiang X, et al. 2023. Cell Discov. 9:7. PubMed
  79. Li B, et al. 2023. Nat Commun. 14:489. PubMed
  80. Schick J, et al. 2023. Elife. 12: . PubMed
  81. Zhu X, et al. 2023. Front Immunol. 14:1114802. PubMed
  82. Zhong CS, et al. 2022. Acta Pharmacol Sin. 43:1324. PubMed
  83. Mecklenburg J, et al. 2022. Brain Behav Immun. 101:246. PubMed
  84. Murotomi K, et al. 2022. Exp Biol Med (Maywood). 247:848. PubMed
  85. Zhao X, et al. 2022. Cell Mol Immunol. 19:540. PubMed
  86. Xin DQ, et al. 2022. Neural Regen Res. 17:2238. PubMed
  87. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  88. Tao X, et al. 2022. J Exp Med. 219:. PubMed
  89. Lopez R, et al. 2022. Nat Biotechnol. 40:1360. PubMed
  90. Gaikwad H, et al. 2022. ACS Nano. . PubMed
  91. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  92. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  93. Narusawa M, et al. 2014. Cancer Immunol Res. 2:568. PubMed
  94. Ostapoff K, et al. 2014. Cancer Res. 74:4966. PubMed
  95. Fan X, et al. 2015. Cancer Res. 75:86. PubMed
  96. Wang L, et al. 2020. Front Cell Dev Biol. 0.745138889. PubMed
  97. Moreno-García Á, et al. 2020. Biomolecules. 10:00. PubMed
  98. Xue F, et al. 2020. Int J Biol Sci. 2.105555556. PubMed
  99. Giorgetti E, et al. 2020. Cell Reports. 29(6):1539-1554.e7.. PubMed
  100. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  101. Fu R, et al. 2020. Sci Rep. 10:1455. PubMed
  102. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  103. Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
  104. Bo Yu et al. 2018. Cell stem cell. 23(2):193-209 . PubMed
  105. Shavit Stein E, et al. 2018. Neural Plast. 2018:7692182. PubMed
  106. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  107. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  108. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  109. Gan C, et al. 2022. Respir Res. 23:32. PubMed
  110. He J, et al. 2022. Front Immunol. 12:760138. PubMed
  111. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  112. Okajima T, et al. 2021. Front Immunol. 12:738041. PubMed
  113. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  114. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  115. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  116. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  117. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  118. Belmonte L, et al. 2016. Sci Rep. 6:35813. PubMed
  119. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  120. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  121. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  122. Zhang YS, et al. 2018. Cancer Biol Ther. 19:735. PubMed
  123. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  124. Wu G, et al. 2020. Front Oncol. 10:194. PubMed
  125. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  126. Lin R, et al. 2020. Sci Rep. 10:14397. PubMed
  127. Koning B, et al. 2006. Int Immunol. 1.403472222. PubMed
  128. Kapadia D, et al. 2011. PLoS One. 6:e19376. PubMed
  129. Pandey S, et al. 2020. Cell Syst. 11:495. PubMed
  130. Tuominen S, et al. 2021. Eur J Nucl Med Mol Imaging. 48:1312. PubMed
  131. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  132. Poli V, et al. 2021. iScience. 24:103256. PubMed
  133. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  134. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  135. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  136. Zhu ZY, et al. 2022. Front Immunol. 12:781087. PubMed
  137. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  138. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  139. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  140. Hu J, et al. 2021. Sci Adv. 7:. PubMed
  141. Chen S, et al. 2022. Cancer Discov. :. PubMed
  142. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  143. Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed
  144. Su N, Xiong Y 2016. Sci Rep. 6:22658. PubMed
  145. Tu S, et al. 2020. Cellular Signalling. 73:109695. PubMed
  146. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  147. Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed
  148. Tong X, et al. 2020. Front Pharmacol. 1.404166667. PubMed
  149. Shang W, et al. 2019. J Diabetes Res. 2019:5641271. PubMed
  150. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  151. Lindborg JA et al. 2017. The Journal of Neuroscience. 37(43):10258-10277 . PubMed
  152. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  153. Duan M, et al. 2022. Cell Commun Signal. 20:60. PubMed
  154. Zhang Q, et al. 2021. Theranostics. 11:8301. PubMed
  155. Li B, et al. 2022. iScience. 25:103772. PubMed
  156. DeMarco JK, et al. 2021. Vaccines (Basel). 9:. PubMed
  157. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  158. Stahnke S, et al. 2021. Current Biology. 31(10):2051-2064.e8. PubMed
  159. Zhang S, et al. 2021. Cell. 184(8):2151-2166.e16. PubMed
  160. Yousif AS, et al. 2020. Immunity. 54(2):235-246.e5. PubMed
  161. Siew JJ, et al. 2019. Nat Commun. 10:3473. PubMed
  162. Verma M, et al. 2018. Brain Behav Immun. 69:223. PubMed
  163. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  164. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  165. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  166. Yang C, et al. 2020. J Control Release. 326:324. PubMed
  167. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  168. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  169. Tanner MA, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H633. PubMed
  170. Kasper M, et al. 2021. Elife. 10:. PubMed
  171. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
  172. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  173. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  174. Guan H, et al. 2012. PLoS One. 7:e35650. PubMed
  175. Caiado F, et al. 2013. Cancer Res. 73:4233. PubMed
  176. Lin T, et al. 2015. PLoS One. 10: e0138335. PubMed
  177. Esmaili S, et al. 2021. Cell Systems. 12(5):432-445.e7. PubMed
  178. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  179. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  180. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  181. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  182. Luo W, et al. 2019. Mol Med Rep. 20:1007. PubMed
  183. Mayers S, et al. 2019. BMC Biotechnol. 19:21. PubMed
  184. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  185. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  186. Kan C, et al. 2022. Bone Res. 10:62. PubMed
  187. Zhang J, et al. 2021. J Leukoc Biol. 110:485. PubMed
  188. Qiu F, et al. 2022. J Cancer. 13:2893. PubMed
  189. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  190. Hou H, et al. 2021. Front Cell Dev Biol. 9:737003. PubMed
  191. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  192. Liang P, et al. 2022. Mol Biomed. 3:14. PubMed
  193. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  194. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  195. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  196. Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
  197. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  198. Periasamy S, et al. 2011. J Leukoc Biol. 90:493. PubMed
  199. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  200. Zong Z, et al. 2019. Front Immunol. 10:1643. PubMed
  201. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  202. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  203. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  204. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  205. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  206. Yao L, et al. 2021. J Bone Miner Res. 36:1159. PubMed
  207. Shen Y, et al. 2022. CNS Neurosci Ther. 28:46. PubMed
  208. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  209. Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed
  210. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  211. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  212. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  213. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  214. Perez–Zsolt D, et al. 2019. Front Immunol. 0.989583333. PubMed
  215. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  216. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  217. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  218. Ye Z, et al. 2019. Mediators Inflamm. 2019:8709583. PubMed
  219. Yuan F, et al. 2022. Front Immunol. 13:798583. PubMed
  220. Forbester JL, et al. 2020. J Virol. 94:. PubMed
  221. Wu H, et al. 2022. Biomolecules. 12:. PubMed
  222. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  223. Gao H, et al. 2021. Cells. 10:. PubMed
  224. Saitoh BY, et al. 2021. Brain Behav Immun. 95:362. PubMed
  225. Marks KE, et al. 2021. Cell Reports. 35(13):109303. PubMed
  226. Ohgomori T, et al. 2020. Neuropharmacology. 176:108227. PubMed
  227. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  228. Köchl R, et al. 2020. Elife. 9:00. PubMed
  229. Lin D, et al. 2015. Proc Natl Acad Sci U S A. 112: 11324-11329. PubMed
  230. Madan-Lala R, et al. 2014. J Immunol. 192:4263. PubMed
  231. Ippolito G, et al. 2014. Proc Natl Acad Sci U S A. 111:998. PubMed
  232. Knolle MD et al. 2018. Frontiers in immunology. 1.925 . PubMed
  233. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  234. Wang F, et al. 2018. Carcinogenesis. 39:889. PubMed
  235. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  236. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  237. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  238. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  239. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  240. Yee PP, et al. 2020. Nat Commun. 4.225. PubMed
  241. Dong S, et al. 2021. Nature. 591:117. PubMed
  242. Dang Y, et al. 2021. J Cancer. 12:7158. PubMed
  243. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  244. Yadav P, et al. 2021. J Immunol. 206:2888. PubMed
  245. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  246. Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
  247. Bao C, et al. 2021. Infect Immun. 89:. PubMed
  248. Tan A, et al. 2012. Mol Pharmacol. 9:2710. PubMed
  249. Cappello P, et al. 2013. Gastroenterology. 144:1098. PubMed
  250. Meraz I, et al. 2014. PLoS One. 9:94703. PubMed
  251. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  252. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  253. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  254. Koivisto CS, et al. 2020. Neoplasia. 1.252777778. PubMed
  255. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  256. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  257. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  258. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  259. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  260. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  261. Wang Q, et al. 2018. Nat Commun. 9:559. PubMed
  262. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  263. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  264. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  265. Shiraki N, et al. 2022. Stem Cell Reports. 17:221. PubMed
  266. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  267. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  268. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  269. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  270. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  271. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  272. Endoh M, et al. 2020. Cell Reports. 30(6):1823-1834. PubMed
  273. Cho K, et al. 2021. iScience. 24:103117. PubMed
  274. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  275. Bakker W, et al. 2021. Int J Mol Sci. 22:. PubMed
  276. Li H, et al. 2021. Nat Commun. 12:7149. PubMed
  277. Shan C, et al. 2021. Front Immunol. 12:766401. PubMed
  278. Sobecki M, et al. 2021. Nat Commun. 12:4700. PubMed
  279. Nishida J, et al. 2022. STAR Protoc. 3:101306. PubMed
  280. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  281. Miller S, et al. 2016. Acta Biochim Biophys Sin. 48: 334-341. PubMed
  282. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  283. Riedelberger M, et al. 2020. Bio Protoc. e3552:10. PubMed
  284. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  285. Simões FC, et al. 2020. Nat Commun. 0.875. PubMed
  286. Ku AT et al. 2017. eLife. 6 pii: e23242. PubMed
  287. Dong L, et al. 2022. Cells. 11:. PubMed
  288. Li Y, et al. 2022. Front Cardiovasc Med. 9:830781. PubMed
  289. Tang C, et al. 2021. Theranostics. 11:9791. PubMed
  290. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  291. Gopinath A, et al. 2022. NPJ Parkinsons Dis. 8:72. PubMed
  292. Sun S, et al. 2021. Front Immunol. 12:777665. PubMed
  293. Lei J, et al. 2021. Theranostics. 4251:11. PubMed
  294. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  295. Chen X, et al. 2016. PLoS One. 11:e0168861. PubMed
  296. Uto T, et al. 2016. Nat Commun. 7: 11273. PubMed
  297. Leon-Rico D, et al. 2015. Lab Anim. 49:132. PubMed
  298. Jäger M, et al. 2018. Antioxid Redox Signal. 30. PubMed
  299. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  300. Liu D, et al. 2020. Front Pharmacol. 11:204. PubMed
  301. Merlo LM, et al. 2020. Clin Pathol. 13:2632010X20951812. PubMed
  302. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
  303. Taddio MF, et al. 2021. Mol Imaging Biol. 23:196. PubMed
  304. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  305. Liu P, et al. 2022. iScience. 25:103867. PubMed
  306. Vasudevan SO, et al. 2022. Cell Rep. 39:110755. PubMed
  307. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  308. Niemi JP, et al. 2020. Methods Mol Biol. 2143:207. PubMed
  309. Dionisio-Santos DA, et al. 2021. Front Neurosci. 15:758677. PubMed
  310. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  311. Ding X, et al. 2015. J Immunol. 194:4251. PubMed
  312. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  313. Takesue S, et al. 2020. Int J Oncol. 56:596. PubMed
  314. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  315. Penkert RR, et al. 2020. Obesity (Silver Spring). 1631:28. PubMed
  316. Zhuo Y, et al. 2018. Oncol Rep. 40:2147. PubMed
  317. Ponzetta A, et al. 2020. Cell. 178(2):346-360.e24.. PubMed
  318. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed
  319. Lima-Junior D, et al. 2017. J Immunol. 10.4049/jimmunol.1700258. PubMed
  320. Stevenson ER, et al. 2022. J Pharmacol Exp Ther. 382:356. PubMed
  321. Chen Y, et al. 2022. Life Sci. 306:120826. PubMed
  322. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  323. Dong R, et al. 2021. Frontiers in Immunology. 12:620238. PubMed
  324. Chen S, et al. 2020. Allergy Asthma Immunol Res. 0.922222222. PubMed
  325. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  326. Chen F, et al. 2016. J Immunol. 196: 4390 - 4399. PubMed
  327. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  328. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  329. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  330. Ohgomori T et al. 2019. J Comp Neurol. 528(1):14-31 . PubMed
  331. Li S, et al. 2019. Front Neurol. 1.036805556. PubMed
  332. He S, et al. 2021. Front Pharmacol. 12:743837. PubMed
  333. Hua X, et al. 2021. Front Immunol. 12:706027. PubMed
  334. Feng L, et al. 2022. Signal Transduct Target Ther. 7:21. PubMed
  335. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  336. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  337. Ostapoff K, et al. 2013. Mol Cancer Ther. 12:1190. PubMed
  338. Macagno M, et al. 2014. J Immunol. 192:5434. PubMed
  339. Chou H, et al. 2015. Proc Natl Acad Sci U S A. 112:2175. PubMed
  340. Quan S, et al. 2015. J Immunol. 194:4175. PubMed
  341. Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed
  342. Yamamuro T, et al. 2020. Nat Commun. 3.340277778. PubMed
  343. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  344. Nasser H, et al. 2020. Cell Death Discov. 0.29375. PubMed
  345. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  346. Kitamura K, et al. 2019. Int J Cardiol Heart Vasc. 23:100344. PubMed
  347. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  348. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  349. Alter C et al. 2019. Am J Physiol Heart Circ Physiol. 317(1):H190-H200 . PubMed
  350. Spolski R et al. 2019. Elife. 8 pii: e45501. PubMed
  351. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  352. Li Q, et al. 2022. Front Oncol. 12:841977. PubMed
  353. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  354. Zhang GL, et al. 2020. Matrix Biol. 93:25. PubMed
  355. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  356. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  357. Mihalik NE, et al. 2021. AAPS PharmSciTech. 22:191. PubMed
  358. Li Y, et al. 2022. STAR Protoc. 3:101364. PubMed
  359. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  360. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  361. Li K, et al. 2020. J Cell Mol Med. 24:13115. PubMed
  362. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  363. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  364. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  365. Glodde N et al. 2017. Immunity. 47(4):789-802 . PubMed
  366. Fox D, et al. 2020. Nat Commun. 0.986111111. PubMed
  367. Deng M, et al. 2019. J Exp Med. 216:2838. PubMed
  368. Chan JY, et al. 2019. Diabetologia. 62:993. PubMed
  369. Adzika GK, et al. 2021. Front Cell Dev Biol. 9:719351. PubMed
  370. Tang S, et al. 2022. Virol J. 19:32. PubMed
  371. Cui Y, et al. 2022. Front Oncol. 12:732860. PubMed
  372. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  373. Tähtinen S, et al. 2022. Nat Immunol. 23:532. PubMed
  374. Patel C, et al. 2022. Curr Protoc. 2:e400. PubMed
  375. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  376. Erin N, et al. 2015. Brain Behav Immun. 48: 174-185. PubMed
  377. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  378. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  379. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  380. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  381. Woods B, et al. 2019. Clin Cancer Res. 25:5901. PubMed
  382. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  383. Calvente CJ, et al. 2019. J Clin Invest. 130:4091. PubMed
  384. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  385. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  386. Uehara M, et al. 2019. Sci Rep. 9:6535. PubMed
  387. Wang Y, et al. 2022. Nat Commun. 13:1454. PubMed
  388. Zhang XL, et al. 2022. J Am Heart Assoc. 11:e023800. PubMed
  389. Wang X, et al. 2022. Elife. 11:. PubMed
  390. Adzika GK, et al. 2021. Front Cardiovasc Med. 8:719805. PubMed
  391. Chen X, et al. 2021. Cell Death Dis. 12:1123. PubMed
  392. Chen J, et al. 2021. Oncol Lett. 21:409. PubMed
  393. Liu SS, et al. 2021. Immunity. :. PubMed
  394. Zhou JH, et al. 2020. Onco Targets Ther. 7.278472222. PubMed
  395. Sitapara RA, et al. 2020. Mol Med. 26:63. PubMed
  396. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  397. Zhong B, et al. 2013. Sci Signal. 6:35. PubMed
  398. Bartley A, et al. 2018. Front Physiol. 9:1593. PubMed
  399. Geng S, et al. 2019. Sci Adv. 5:eaav2309. PubMed
  400. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  401. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  402. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  403. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
  404. Luo ZW, et al. 2021. Int J Nanomedicine. 16:2949. PubMed
  405. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  406. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  407. Shin SH, et al. 2022. Clin Exp Otorhinolaryngol. . PubMed
  408. Palma A, et al. 2022. Front Cell Dev Biol. 10:841548. PubMed
  409. Jia J, et al. 2022. Nat Commun. 13:6804. PubMed
  410. Hegde V, et al. 2015. J Immunol. 194:5211. PubMed
  411. Chen MB, et al. 2020. Cell Rep. 30:4418. PubMed
  412. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  413. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  414. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  415. Ribechini E, et al. 2017. Blood Adv. 0.699305556. PubMed
  416. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  417. Moriyasu T, et al. 2018. PLoS Negl Trop Dis. 12:e0006197. PubMed
  418. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  419. Wang S, et al. 2022. Blood. 140:171. PubMed
  420. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  421. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  422. Wu KKL, et al. 2021. Nat Commun. 12:6637. PubMed
  423. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  424. Xue Y, et al. 2020. Sci Rep. 10:22265. PubMed
  425. Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed
  426. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  427. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  428. Koronyo Y, et al. 2015. Brain. 138: 2399-2422. PubMed
  429. Zhao Y, et al. 2013. J Leukoc Biol. 94:1103. PubMed
RRID
AB_312788 (BioLegend Cat. No. 101205)
AB_312788 (BioLegend Cat. No. 101206)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
KIRAVIA Blue 520™ anti-mouse/human CD11b M1/70 FC
PE/Fire™ 744 anti-mouse/human CD11b M1/70 FC
Spark PLUS UV395™ anti-mouse/human CD11b M1/70 FC
Spark Red™ 718 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account